Sorted By:

Relevance


Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

PhRMA  |  Blog Post

In case you missed it, nearly 400 groups across the health care industry sent a letter to Congress last session opposing this exact proposal.
http://catalyst.phrma.org/medicare-monday-why-imposing-medicaid-style-rebates-in-part-d-is-a-bad-idea

Director – Federal Advocacy

PhRMA  |  PhRMA Career

www.Innovation.orgwww.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members. 
https://www.phrma.org

In the OECD other health care services will be ten times prescription medicine spending growth over next decade

PhRMA  |  Blog Post

Prescription medicines are often the most cost-effective means of preventing and treating disease, and they help patients avoid hospitalizations and other costly health care services.
http://catalyst.phrma.org/in-the-oecd-other-health-care-services-will-be-ten-times-prescription-medicine-spending-growth-over-next-decade

Medicines in Development for Children 2012 Report

PhRMA  |  Report

The more than 300 medicines in development listed in the new report reflect these ongoing efforts.
https://www.phrma.org/report/medicines-in-development-for-children-report

Fact Check Friday: The truth about biopharmaceutical patents

PhRMA  |  Blog Post


http://catalyst.phrma.org/fact-check-friday-the-truth-about-biopharmaceutical-patents

ICYMI: The New Era of Medicine initiative spotlights genomics in NYC

PhRMA  |  Blog Post

Genomics technologies have allowed us to design rapid response platform technologies: those could be our best bet for the rapid production and scale up of a new vaccine.” - Ripley Ballou, Vice President of Vaccines, GSK Click here to watch the full video and learn more at innovation.org
http://catalyst.phrma.org/icymi-the-new-era-of-medicine-initiative-spotlights-genomics-in-nyc

Stakeholders Agree: Modernize the legal framework to support move to value-driven health care

PhRMA  |  Blog Post

Modernizing certain laws and regulations to support the move to value-drive health care is an important step in moving our health care system forward.
http://catalyst.phrma.org/stakeholders-agree-modernize-the-legal-framework-to-support-move-to-value-driven-health-care

A new era in cancer

PhRMA  |  Blog Post

The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment.
http://catalyst.phrma.org/a-new-era-in-cancer

Fact Check Friday: The truth about IPAB

PhRMA  |  Blog Post

MYTH: The Independent Payment Advisory Board cannot propose or make cuts to Medicare without convening a 15-member board nominated by the President and confirmed by the Senate.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-ipab

New JAMA Study Highlights Continued Success of Medicare Part D

PhRMA  |  Press Release

  The JAMA study can found online at: http://jama.ama-assn.org/content/306/4/402.short    RELATED VIDEO: http://youtu.be/eHRfRY74NCQ   Find PhRMA Online: Website – http://www.phrma.org Facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress  For information on how innovative medicines save lives, visit: http://www.innovation.orgFor information on the Partnership for Prescription Assistance, visit: http://www.pparx.orgFor information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/new-jama-study-highlights-continued-success-of-medicare-part-d

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Learn more about the impact on patients and why additional charity care requirements for hospitals that participate in the 340B program should be considered.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-november-20-2015

Poll respondents appreciate economic benefits of innovation and call for more protections

PhRMA  |  Blog Post

Survey findings indicate that Americans not only understand which industries bring innovative products and processes to the public, they also recognize the importance of protecting these industries and U.S. innovation more generally.
http://catalyst.phrma.org/poll-respondents-appreciate-economic-benefits-of-innovation-and-call-for-more-protections

Honoring veterans serving in the biopharmaceutical industry

PhRMA  |  Blog Post

Caskey noted that he’s encouraged by the veteran hiring initiatives across the biopharmaceutical industry, including Merck, Pfizer and Eli Lilly which represent just some of the many companies that have programs in place aimed at hiring veterans.
http://catalyst.phrma.org/honoring-veterans-serving-in-the-biopharmaceutical-industry

Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist

PhRMA  |  Blog Post

Check out the other exciting GOBOLDLY™ advertisements launched so far this year.
http://catalyst.phrma.org/fighting-multiple-sclerosis-new-together-ad-illuminates-the-journey-of-patient-scientist

Medicare Monday: Another example of the competitive market at work in Part D

PhRMA  |  Blog Post

What does this significant change mean?
http://catalyst.phrma.org/medicare-monday-another-example-of-the-competitive-market-at-work-in-part-d

Examining the brain in The New Era of Medicine

PhRMA  |  Blog Post

We’ll hear from those at the helm of research and innovation, from biopharmaceuticals to brain machine interfaces.
http://catalyst.phrma.org/examining-the-brain-in-the-new-era-of-medicine

ICYMI – 3 new reports show dramatic slowdown in medicine spending growth

PhRMA  |  Blog Post

This study begs an important question: Are we doing enough to ensure the growing amount of rebates and discounts flow to the patient?
http://catalyst.phrma.org/icymi-3-new-reports-show-dramatic-slowdown-in-medicine-spending-growth

Medicare Monday: Negotiation in Medicare Part D works

PhRMA  |  Blog Post

Substantial negotiation in Medicare Part D works to keep costs low for beneficiaries and taxpayers.
http://catalyst.phrma.org/medicare-monday-negotiation-in-medicare-part-d-works

Fact Check Friday: The truth about drug importation and patient safety

PhRMA  |  Blog Post

This week on Fact Check Friday, we’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-drug-importation-and-patient-safety

New Policy Solutions for Innovative Treatment Delivery

PhRMA  |  Press Release

Addressing distortions in the market – like the rapidly growing 340B program, or the risk adjuster for commercial insurance that does not account for prescription drug costs – would help preserve the safety net, revive the health care market and improve affordable access to medicines for patients.
https://www.phrma.org/press-release/phrma-releases-new-policy-solutions-for-delivering-innovative-treatments-to-patients

Medicare Monday: Managing Chronic Conditions

PhRMA  |  Blog Post

here.
http://catalyst.phrma.org/medicaremonday-managing-chronic-conditions

PhRMA Statement on Ensuring Continued Medical Progress

PhRMA  |  Press Release

These companies deliver clear benefits to patients in the form of a steady supply of new Pharmaceutical Research and Manufacturers of America 950 F Street, NW, Suite 300 * Washington, DC 20004 * (202) 835-3400 medical therapies and have helped to stabilize local budgets and the national economy. 
https://www.phrma.org/press-release/phrma-statement-on-ensuring-continued-medical-progress

Medicare Monday: Looking back at the success of Part D in its first 10 years

PhRMA  |  Blog Post

The program also keeps costs low for taxpayers, with total Part D costs coming in $349 billion less than the initial 10-year projections.
http://catalyst.phrma.org/looking-back-at-the-success-of-part-d-in-its-first-10-years

Senior Manager – Advocacy and Strategic Alliances

PhRMA  |  PhRMA Career

www.Innovation.orgwww.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offer In addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members.
https://www.phrma.org

New report portrays flourishing pipeline

PhRMA  |  Blog Post


http://catalyst.phrma.org/new-report-portrays-flourishing-pipeline

You have reviewed the first 175 results out of 430. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next